Literature DB >> 9347413

Familial risk ratios for extreme obesity: implications for mapping human obesity genes.

J H Lee1, D R Reed, R A Price.   

Abstract

OBJECTIVE: To determine familial risk ratios for extreme obesity to aid in the design of obesity linkage studies.
DESIGN: Family study of obesity.
SUBJECTS: 2349 first-degree relatives (parents and siblings) of 840 probands who are members of the National Association to Advance Fat Acceptance (NAAFA) and 5851 participants of the first phase of the National Health and Nutrition Examination Survey III.
METHODS: Computed age-gender standardized risk ratios (SRRs) for obesity in relatives categorized by the level of obesity in the index case (proband). MEASUREMENT: Body mass index (BMI) (kg/m2).
RESULTS: The risk of extreme obesity (BMI > or = 40) in relatives of extremely obese women (BMI > or = 40) was more than five times greater than in the population; furthermore, the risk of obesity in relatives was approximately linearly associated with the degree of obesity in the proband. The risk of thinness in relatives of obese individuals was substantially lower than in the general population.
CONCLUSION: Because the familial risk ratio for extreme obesity is higher than for moderate levels of obesity, the number of families required to achieve adequate statistical power in gene mapping studies of obesity can be reduced substantially by focusing on family members of extremely obese individuals (BMI > or = 40).

Entities:  

Mesh:

Year:  1997        PMID: 9347413     DOI: 10.1038/sj.ijo.0800498

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  13 in total

1.  Quantitative-trait-locus analysis of body-mass index and of stature, by combined analysis of genome scans of five Finnish study groups.

Authors:  M Perola; M Ohman; T Hiekkalinna; J Leppävuori; P Pajukanta; M Wessman; M Koskenvuo; A Palotie; K Lange; J Kaprio; L Peltonen
Journal:  Am J Hum Genet       Date:  2001-06-15       Impact factor: 11.025

Review 2.  Pharmacogenetics of antipsychotic-induced weight gain.

Authors:  Christoph U Correll; Anil K Malhotra
Journal:  Psychopharmacology (Berl)       Date:  2004-07-08       Impact factor: 4.530

3.  Bariatric Surgery Patients and Their Families: Health, Physical Activity, and Social Support.

Authors:  Michelle R Lent; Lisa Bailey-Davis; Brian A Irving; G Craig Wood; Adam M Cook; Annemarie G Hirsch; Christopher D Still; Peter N Benotti; Jennifer Franceschelli-Hosterman
Journal:  Obes Surg       Date:  2016-12       Impact factor: 4.129

4.  Childhood obesity: are genetic differences involved?

Authors:  Claude Bouchard
Journal:  Am J Clin Nutr       Date:  2009-03-04       Impact factor: 7.045

Review 5.  Candidate gene studies of antipsychotic drug efficacy and drug-induced weight gain.

Authors:  Anil K Malhotra
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 6.  How obesity develops: insights from the new biology.

Authors:  D York; C Bouchard
Journal:  Endocrine       Date:  2000-10       Impact factor: 3.925

7.  Molecular basis of obesity: current status and future prospects.

Authors:  Hélène Choquet; David Meyre
Journal:  Curr Genomics       Date:  2011-05       Impact factor: 2.236

8.  Evidence that obesity risk factor potencies are weight dependent, a phenomenon that may explain accelerated weight gain in western societies.

Authors:  Paul T Williams
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

9.  Can we modify the intrauterine environment to halt the intergenerational cycle of obesity?

Authors:  Kristi B Adamo; Zachary M Ferraro; Kendra E Brett
Journal:  Int J Environ Res Public Health       Date:  2012-04-16       Impact factor: 3.390

10.  Moderators of the intention-behaviour and perceived behavioural control-behaviour relationships for leisure-time physical activity.

Authors:  Steve Amireault; Gaston Godin; Marie-Claude Vohl; Louis Pérusse
Journal:  Int J Behav Nutr Phys Act       Date:  2008-02-01       Impact factor: 6.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.